Analysts Set Esperion Therapeutics, Inc. (NASDAQ:ESPR) PT at $6.75
Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) have been given an average rating of “Moderate Buy” by the six research firms that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and four have issued a buy […]
Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) have been given an average rating of “Moderate Buy” by the six research firms that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and four have issued a buy […]
